1. Home
  2. VTSI vs EQ Comparison

VTSI vs EQ Comparison

Compare VTSI & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTSI
  • EQ
  • Stock Information
  • Founded
  • VTSI 1993
  • EQ 2017
  • Country
  • VTSI United States
  • EQ United States
  • Employees
  • VTSI N/A
  • EQ N/A
  • Industry
  • VTSI Miscellaneous manufacturing industries
  • EQ Biotechnology: Pharmaceutical Preparations
  • Sector
  • VTSI Consumer Discretionary
  • EQ Health Care
  • Exchange
  • VTSI Nasdaq
  • EQ Nasdaq
  • Market Cap
  • VTSI 60.6M
  • EQ 67.9M
  • IPO Year
  • VTSI N/A
  • EQ 2018
  • Fundamental
  • Price
  • VTSI $5.83
  • EQ $1.91
  • Analyst Decision
  • VTSI Strong Buy
  • EQ Hold
  • Analyst Count
  • VTSI 1
  • EQ 2
  • Target Price
  • VTSI $7.00
  • EQ $1.00
  • AVG Volume (30 Days)
  • VTSI 77.8K
  • EQ 16.0M
  • Earning Date
  • VTSI 08-11-2025
  • EQ 08-14-2025
  • Dividend Yield
  • VTSI N/A
  • EQ N/A
  • EPS Growth
  • VTSI N/A
  • EQ N/A
  • EPS
  • VTSI 0.10
  • EQ N/A
  • Revenue
  • VTSI $27,068,543.00
  • EQ $16,553,000.00
  • Revenue This Year
  • VTSI $10.31
  • EQ N/A
  • Revenue Next Year
  • VTSI $12.71
  • EQ N/A
  • P/E Ratio
  • VTSI $58.35
  • EQ N/A
  • Revenue Growth
  • VTSI N/A
  • EQ N/A
  • 52 Week Low
  • VTSI $3.57
  • EQ $0.27
  • 52 Week High
  • VTSI $8.53
  • EQ $2.35
  • Technical
  • Relative Strength Index (RSI)
  • VTSI 45.93
  • EQ 70.45
  • Support Level
  • VTSI $5.67
  • EQ $1.50
  • Resistance Level
  • VTSI $6.08
  • EQ $1.90
  • Average True Range (ATR)
  • VTSI 0.25
  • EQ 0.35
  • MACD
  • VTSI 0.02
  • EQ 0.00
  • Stochastic Oscillator
  • VTSI 64.47
  • EQ 65.63

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

About EQ Equillium Inc.

Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its product candidates either independently or through partnerships, or otherwise monetize its pipeline through strategic transactions. Itolizumab (EQ001), a clinical-stage product candidate, is an anti-CD6 immune-modifying monoclonal antibody, or mAb, that selectively targets the CD6-ALCAM signaling pathway to downregulate pathogenic T effector cells while preserving T regulatory cells critical for maintaining a balanced immune response. The company's other clinical-stage and pre-clinical-stage candidates include EQ101 and EQ302.

Share on Social Networks: